DP Cap Acquisition Corp I: Nasdaq/NYSE listing notice — DP Cap Acquisition Corp I receives Nasdaq delisting notice for low MVLS; compliance period until Feb 2024

DP Cap Acquisition Corp I

Nasdaq letter on Aug 21, 2023: MVLS below $50M minimum required by Listing Rule 5450(b)(2)(A).
Compliance period runs through Feb 20, 2024; regain compliance by maintaining MVLS ≥ $50M for 10 consecutive business days.
Company may evaluate transfer to Nasdaq Capital Market to cure deficiency.
No immediate effect on listing; shares (DPCS, DPCSW, DPCSU) continue trading on Nasdaq Global Market.
Risk of delisting if non-compliance persists after Feb 2024; forward-looking statements caution.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

DP Cap Acquisition Corp I received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5810(c)(3)(C)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5450(b)(2)(A), 5810(c)(3)(C)

Exact text from the filing

August 21, 2023, DP Cap Acquisition Corp. (the “Company”) received a letter (the “Nasdaq Letter”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company is not in compliance with Nasdaq Listing Rule 5450(b)(2)(A), which requires that the Company’s listed securities maintain a minimum Market Value of Listed Securities (“MVLS”) of $50 million. The Nasdaq Letter further provided that, pursuant to Nasdaq Listing Rule 5810(c)(3)(C), the Company is entitled to a compliance period to regain compliance with Nasdaq Listing Rule 5450(b)(

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001140361-23-040960

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.